Calyx Announces Commercial Launch of Higher Yielding Variety of Resonance(R) Carinata

Calyx Bio-Ventures Inc. (TSX VENTURE:CYX) is pleased to announce the commercial
launch of an improved variety of Resonance(R) carinata, an industrial oilseed
crop that is proprietary to Calyx's operating subsidiary, Agrisoma Biosciences
Inc. Oil extracted from carinata can be refined into fuels used as 100 percent
petroleum substitutes.


Performance trials of this next-generation variety of Resonance carinata, AAC
A110, delivered an average yield improvement of 7% compared to the existing
Resonance carinata variety, AAC A100 (where yield is measured as the weight of
the crop harvested per acre). AAC A110 also demonstrated an improved meal
profile. The AAC A110 variety was developed and extensively field-tested over
the last three growing seasons at multiple locations in Western Canada.


"The yield improvements from AAC A110 enables production of more oil for every
acre planted, compared to the AAC A100 line. This further substantiates the
value proposition for Resonance carinata to become the leading oilseed crop for
the biofuel industry," said Hugh Notman, CEO of Calyx. "Continuing to develop
higher yielding varieties is a high priority for our company."


Performance trials of AAC A110 resulted in yields as high as 44 bushels per
acre. AAC A110 also resulted in an improved meal (the resulting byproduct of
carinata after the oil has been extracted) profile. Resonance carinata produces
a high-soluble protein meal that can be sold into the cattle feed market.


AAC A110 has the same seeding rates and crop inputs (fertilizer, weed and insect
control) as A100, and costs the same to produce, treat, clean and deliver to
farmers.


"Ultimately we get a better crop that results in even better land utilization,
which has implications across the entire value chain," Notman said. "Equally
important is that the production and use of carinata as a fuel substantially
reduces carbon and other harmful emissions."


Beginning with the current planting season, AAC A110 will be the variety of
Resonance carinata sold for commercial production.


About Calyx 

Calyx Bio-Ventures Inc. (TSX VENTURE:CYX) is an agricultural technology company
focused on renewable fuels including biojet and biodiesel. Calyx's
majority-owned operating subsidiary, Agrisoma Biosciences Inc., is producing a
new proprietary non-food energy feedstock crop, Resonance(R) carinata, which
yields oil that can be refined into fuels that work in existing engines as a 100
percent petroleum substitute. From seed to sky, fuels produced from Resonance(R)
carinata substantially reduce carbon and other harmful emissions, and help to
reduce global petroleum dependence. For further information about Calyx, please
visit www.calyxbio.com. Resonance(R) is a registered trademark of Agrisoma
Biosciences Inc.


Forward-Looking Statements: This document contains certain forward-looking
statements concerning Calyx and/or Agrisoma, as well as other expectations,
plans, goals, objectives, information or statements about future events,
conditions, results of operations or performance that may constitute
"forward-looking statements" or "forward-looking information" under applicable
securities legislation. Such statements or information involve substantial known
and unknown risks and uncertainties, certain of which are beyond Calyx's and/or
Agrisoma's control, including general business, economic, competitive, political
and social uncertainties; the delay or failure to receive regulatory approvals,
the characteristics and viability for bio-fuel development, the willingness of
third parties to conclude agreements with Calyx and/or Agrisoma on terms that
are acceptable to management of Calyx and/or Agrisoma, and the ability of Calyx
and/or Agrisoma to secure sufficient future funding to carry out all of its
business plans.


Such forward-looking statements or information are based on a number of
assumptions, which may prove to be incorrect. In addition to other assumptions
identified in this news release, assumptions have been made regarding, among
other things, commodity prices, operating conditions, capital and other
expenditures, and project development activities.


Although Calyx and/or Agrisoma believes that the expectations reflected in such
forward-looking statements or information are reasonable, undue reliance should
not be placed on forward-looking statements because Calyx and/or Agrisoma can
give no assurance that such expectations will prove to be correct.
Forward-looking statements or information are based on current expectations,
estimates and projections that involve a number of risks and uncertainties which
could cause actual results to differ materially from those anticipated by Calyx
and/or Agrisoma and described in the forward-looking statements or information.


The forward-looking statements or information contained in this news release are
made as of the date hereof and Calyx and/or Agrisoma undertakes no obligation to
update publicly or revise any forward-looking statements or information, whether
as a result of new information, future events or otherwise unless so required by
applicable securities laws or the TSX Venture Exchange. The forward-looking
statements or information contained in this news release are expressly qualified
by this cautionary statement.


This press release shall not constitute an offer to sell, nor the solicitation
of an offer to buy, any securities in the United States, nor shall there be any
sale of securities mentioned in this press release in any state in the United
States in which such offer, solicitation or sale would be unlawful prior to
registration or qualification under the securities laws of any such state.


FOR FURTHER INFORMATION PLEASE CONTACT: 
Calyx Bio-Ventures Inc.
W. Hugh Notman
President & CEO
604-689-2495
hnotman@calyxbio.com


Calyx Bio-Ventures Inc.
Keir Reynolds
Investor Relations
778-998-9242
kreynolds@calyxbio.com
www.calyxbio.com
Calyx Ventures (TSXV:CYX)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024